Prevalence of impaired glucose tolerance among children and adolescents with obesity. 2012

F Mohsin, and S Mahbuba, and T Begum, and K Azad, and N Nahar
Department of Paediatrics, Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders and Ibrahim Medical College, Dhaka, Bangladesh. fauzia_mohsin@yahoo.com

The study was undertaken to see the prevalence of impaired glucose tolerance among children and adolescents with obesity, attending the Paediatric Endocrine OPD, Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic disorders (BIRDEM), Dhaka, Bangladesh. A cross sectional study from January 2006 to December 2008 was conducted among obese children and adolescents (6-18 years). Children with any other endocrine disorder, dysmorphism/syndrome were excluded. Obesity was defined as BMI ≥ 95th percentile for age and sex using CDC growth chart. Children underwent two hours oral glucose tolerance test with 1.75 gm/kg or 75 gm of glucose, anthropometric and blood pressure measurement. Fasting serum insulin and lipid profile were measured. Impaired glucose tolerance (IGT) was defined as fasting plasma glucose (FPG) <7 mmol/L and 2 hours post glucose load ≥ 7.8 mmol/L to <11.1 mmol/L. Diabetes mellitus (DM) was defined as FPG ≥ 7 mmol/L or 2 hours post glucose load ≥ 11.1 mmol/L. Homeostasis model assessment was used to estimate insulin resistance. A total of 161 children presented with obesity. Male to female ratio was 1.3:1. Mean age was 10.3 ± 2 .5 years. Mean BMI was 27.86 ± 4.1 kg/m². IGT was found in 16.9% of children and adolescents. In children aged 6-10 years IGT was detected in 16.1% and in adolescents aged 11-18 years IGT was detected in 20%. Diabetes mellitus was detected in 2.1% of subjects, all were adolescents. Serum fasting insulin and hip circumference were significantly higher among children and adolescents with IGT compared to that of normal glucose tolerance. The high rate of IGT among obese children and adolescents is of concern. Factors contributing towards obesity needs to be identified and strategies should be planned for prevention and management of this health problem.

UI MeSH Term Description Entries
D008297 Male Males
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D018149 Glucose Intolerance A pathological state in which BLOOD GLUCOSE level is less than approximately 140 mg/100 ml of PLASMA at fasting, and above approximately 200 mg/100 ml plasma at 30-, 60-, or 90-minute during a GLUCOSE TOLERANCE TEST. This condition is seen frequently in DIABETES MELLITUS, but also occurs with other diseases and MALNUTRITION. Impaired Glucose Tolerance,Glucose Intolerances,Glucose Tolerance, Impaired,Glucose Tolerances, Impaired,Impaired Glucose Tolerances,Intolerance, Glucose,Intolerances, Glucose,Tolerance, Impaired Glucose,Tolerances, Impaired Glucose

Related Publications

F Mohsin, and S Mahbuba, and T Begum, and K Azad, and N Nahar
March 2002, The New England journal of medicine,
F Mohsin, and S Mahbuba, and T Begum, and K Azad, and N Nahar
April 2017, Journal of endocrinological investigation,
F Mohsin, and S Mahbuba, and T Begum, and K Azad, and N Nahar
June 1991, Minerva medica,
F Mohsin, and S Mahbuba, and T Begum, and K Azad, and N Nahar
July 2010, Therapeutics and clinical risk management,
F Mohsin, and S Mahbuba, and T Begum, and K Azad, and N Nahar
February 2005, Nihon rinsho. Japanese journal of clinical medicine,
F Mohsin, and S Mahbuba, and T Begum, and K Azad, and N Nahar
July 2002, The New England journal of medicine,
F Mohsin, and S Mahbuba, and T Begum, and K Azad, and N Nahar
July 2002, The New England journal of medicine,
F Mohsin, and S Mahbuba, and T Begum, and K Azad, and N Nahar
July 2002, The New England journal of medicine,
F Mohsin, and S Mahbuba, and T Begum, and K Azad, and N Nahar
July 2002, The New England journal of medicine,
F Mohsin, and S Mahbuba, and T Begum, and K Azad, and N Nahar
July 2002, The New England journal of medicine,
Copied contents to your clipboard!